Surgical resection plus biotherapy/chemotherapy improves survival of hepatic metastatic melanoma.

@article{Du2012SurgicalRP,
  title={Surgical resection plus biotherapy/chemotherapy improves survival of hepatic metastatic melanoma.},
  author={Shunda Du and Yi-lei Mao and Shaohua Li and Xinting Sang and Xin Lu and Yi-yao Xu and Haifeng Xu and Lin Zhao and Chunmei Bai and Shou-xian Zhong and Jie-fu Huang},
  journal={World journal of hepatology},
  year={2012},
  volume={4 11},
  pages={
          305-10
        },
  url={https://api.semanticscholar.org/CorpusID:10959229}
}
Surgical operation should be first choice for HMM treatment, and together with biotherapy/chemotherapy, hepatectomy is likely to bring better prognosis.
[PDF] Semantic Reader
5 Citations
Highly Influential Citations
1
Background Citations
1

Figures and Tables from this paper

5 Citations

Surgical treatment of a metastatic melanoma patient after targeted therapy

The article presents issues of diagnosis, course of disease, results of target therapy and surgery of a patient with metastatic melanoma, who was diagnosed skin metastatic melanoma with multiple soft tissue lesions in the body, right thigh, left inguinal area and left ovary.

Melanoma m1: diagnosis and therapy.

The association of newer drugs and new biological therapies such as ipilimumab and verumafenib have improved the treatment landscape of stage IV melanoma and the palliative role of radiotherapy in relation to various metastatic sites, chemotherapy and recently introduced targeted-therapy.

Melanoma m 1 : Diagnosis and Therapy

The sequential and non-linear models of development and progression of melanoma and the main molecular disorder involved in these processes are examined and the palliative role of radiotherapy in relation to various metastatic sites, chemotherapy and recently introduced targeted-therapy are discussed.

Surgery for liver metastases from primary melanoma: a systematic review and meta-analysis

It is suggested that surgical treatment of melanoma liver metastases could offer better OS outcomes compared with non-surgical treatment.

The benefits of liver resection for non-colorectal, non-neuroendocrine liver metastases: a systematic review

There appears to be a benefit to resection for patients with NCRNNE liver metastases and the degree of survival advantage is predicated by primary site, as observed in a systematic review of the previous literature.

35 References

Long-term survival of uveal melanoma patients after surgery for liver metastases

It is shown that it is possible to extend significantly the life expectancy of uveal melanoma patients who develop isolated hepatic metastases by complete resection of the lesions through posthepatectomy.

Surgical treatment of metastatic melanoma.

Outcome of patients following hepatic resection for metastatic cutaneous and ocular melanoma

Liver resection may be considered as part of oncosurgical treatment in patients with melanoma liver metastases, since prolonged survival was observed, albeit with a high recurrence rate.

Liver Resection for Metastatic Melanoma with Postoperative Tumor-Infiltrating Lymphocyte Therapy

Resection of MML with TIL should be considered because it can result in prolonged survival in a highly selected group of patients.

Liver resection and cryotherapy for metastatic melanoma.

Those who were selected and underwent surgery had a better overall survival compared with patients who are treated nonoperatively, and patients with ocular primary, single lesions, and unilobar disease had aBetter outcome.

Hepatic Resection for Noncolorectal Nonendocrine Liver Metastases: Analysis of 1452 Patients and Development of a Prognostic Model

HR for NCNELM is safe and effective, with outcomes mainly dependent on primary tumor site and histology, and a statistical model based on key prognostic factors could validate the indication for hepatic resection by predicting long-term survivals.

The role of surgery in treatment of stage IV melanoma

Without effective alternate treatments, surgery must be considered the primary treatment of melanoma, independent of disease stage, and clear and durable survival advantages for patients undergoing complete resection of metastatic melanoma are demonstrated.

Hepatic Resection for Metastatic Melanoma: Distinct Patterns of Recurrence and Prognosis for Ocular Versus Cutaneous Disease

Patterns of recurrence and prognosis after resection of hepatic melanoma metastasis differ depending on whether the primary melanoma is ocular or cutaneous, and should be performed as part of a multidisciplinary approach.

Prognostic factors in 1,521 melanoma patients with distant metastases.

Despite new treatment options, the survival rate of patients with metastatic melanoma has not changed significantly over the last 22 years; their prognosis remains dismal.

Metastatic patterns, clinical outcome, and malignant phenotype in malignant cutaneous melanoma.

Patients with primary distant skin, distant lymph node, or pulmonary metastases had a significantly better survival compared with those with CNS, bone, visceral, liver, or multiple sites of first distant metastases.